Related Experiment Video
Updated: Aug 15, 2025

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
Circ_0026218 ameliorates oxidized low-density lipoprotein-induced vascular endothelial cell dysfunction by regulating
Jing Liu1, Xiangyang Zhang2, Zhaoxia Yu3
1Departments of coronary heart disease, First Affiliated Hospital of Xinjiang Medical University, Urumqi City, China.
Insights
Knocking down circular RNA circ_0026218 alleviates atherosclerosis by regulating the microRNA-188-3p/toll-like receptor 4/NF-κB pathway in human umbilical vein endothelial cells.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- RNA Biology
Background:
- Circular RNAs (circRNAs) are implicated in cardiovascular diseases like atherosclerosis (AS).
- The specific role and mechanism of circ_0026218 in AS pathogenesis remain largely unknown.
- Understanding circRNA regulation is crucial for developing novel therapeutic strategies for AS.
Purpose of the Study:
- To investigate the function and mechanism of circ_0026218 in atherosclerosis.
- To determine the regulatory relationship between circ_0026218, microRNA-188-3p (miR-188-3p), and toll-like receptor 4 (TLR4) in endothelial cells.
- To explore the potential of circ_0026218 as a therapeutic target for AS.
Main Methods:
- Established an in vitro cell model of AS using oxidized low-density lipoprotein (ox-LDL)-treated human umbilical vein endothelial cells (HUVECs).
- Quantified expression levels of circ_0026218, miR-188-3p, and TLR4 in patient serum and cell models using RT-qPCR.
- Assessed cell proliferation, apoptosis, inflammation, oxidative stress, and nitric oxide production using various assays (CCK-8, EdU, flow cytometry, ELISA, NO assay).
- Investigated molecular interactions using dual-luciferase reporter, RNA immunoprecipitation (RIP), and RNA pull-down assays.
- Analyzed exosome characteristics and presence using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA).
Main Results:
- Ox-LDL induced HUVEC dysfunction, characterized by inhibited proliferation, increased apoptosis, inflammation, and oxidative stress.
- Circ_0026218 expression was significantly upregulated in AS patient serum and ox-LDL-treated HUVECs.
- Knockdown of circ_0026218 ameliorated ox-LDL-induced HUVEC dysfunction.
- Circ_0026218 sponged miR-188-3p, and miR-188-3p targeted TLR4, collectively regulating the TLR4/NF-κB pathway.
- Circ_0026218 was found to be packaged and transferred via exosomes.
Conclusions:
- Circ_0026218 plays a critical role in promoting endothelial cell dysfunction in atherosclerosis.
- The circ_0026218/miR-188-3p/TLR4/NF-κB axis represents a key regulatory pathway in AS pathogenesis.
- Circ_0026218, particularly when delivered via exosomes, is a potential therapeutic target for atherosclerosis.
Background:
Circular RNAs (circRNAs) have shown important regulatory roles in cardiovascular diseases, including atherosclerosis (AS). However, the role and mechanism of circ_0026218 in AS remain unclear.
Methods:
The cell model of AS in vitro was established by stimulating human umbilical vein endothelial cells (HUVECs) with oxidized low-density lipoprotein (ox-LDL). In addition, circ_0026218, microRNA-188-3p (miR-188-3p), and toll-like receptor 4 (TLR4) expression was determined via real-time quantitative polymerase chain reaction (RT-qPCR) in serum samples from AS patients and healthy volunteers. Cell proliferation was assessed using Cell Counting Kit-8 (CCK-8) assay and 5-ethynyl-2'-deoxyuridine (EdU) assay. Cell apoptosis was measured using flow cytometry. The inflammatory response was assessed using enzyme-linked immunosorbent assay (ELISA). Oxidative stress level was assessed using corresponding kits. Nitric oxide (NO) level was examined using NO detection assay. The interaction between miR-188-3p and circ_0026218 or TLR4 was determined via dual-luciferase reporter, RNA immunoprecipitation (RIP), and RNA pull-down assays. Exosomes were observed using transmission electron microscopy (TEM). The size distribution of exosomes was analyzed using nanoparticle tracking analysis (NTA).
Results:
Ox-LDL treatment caused HUVEC dysfunction by inhibiting cell proliferation and promoting apoptosis, inflammation, and oxidative stress. Circ_0026218 was upregulated in AS serum samples and ox-LDL-treated HUVECs. Knockdown of circ_0026218 attenuated ox-LDL-induced dysfunction in HUVECs. MiR-188-3p acted as a target of circ_0026218, and miR-188-3p downregulation reversed the suppression role of circ_0026218 knockdown on ox-LDL-induced HUVEC disorder. TLR4 was a target of miR-188-3p, and miR-188-3p overexpression alleviated ox-LDL-induced dysfunction in HUVECs by targeting TLR4. Circ_0026218 could deregulate the TLR4/NF-κB pathway by sponging the miR-188-3p. Importantly, circ_0026218 was overexpressed in exosomes from ox-LDL-treated HUVECs and could be delivered via exosomes.
Conclusion:
Circ_0026218 knockdown attenuated ox-LDL-induced dysfunction in HUVECs via regulating miR-188-3p/TLR4/NF-κB pathway.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Nitric Oxide Signaling Pathway
Cholesterol: Significance and Regulation
Considering cholesterol and...
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply

